Literature DB >> 26219585

Hypobaric hypoxia is not a direct dyspnogenic factor in healthy individuals at rest.

Takayuki Nakano1, Masayuki Iwazaki2, Gen Sasao3, Asuka Nagai4, Akinori Ebihara5, Tokuzen Iwamoto6, Ichiro Kuwahira7.   

Abstract

Dyspnea consists of various uncomfortable respiratory sensations. It is believed that hypoxia causes dyspnea, but whether hypoxia is a direct dyspnogenic factor remains uncertain. We investigated whether hypoxia has a direct dyspnogenic effect. We evaluated changes in vital signs, arterial blood gases, SaO2, CaO2, Borg scale, and Mini-Mental State Examination in seven mountain climbers by using a hypobaric hypoxic chamber in which the barometric pressure was lowered to the simulated altitude of 4500 m. PaO2 and CaO2 both decreased significantly as the simulated altitude increased. On the other hand, Borg scale score which reflects dyspnea showed no significant difference. At the simulated altitude of 4500 m, Borg scale score was 1.5 ± 1.2 (mean ± SD), despite the presence of absolute hypoxia (PaO2, 46.8 ± 8.3T; CaO2, 16.4 ± 0.6 mL/dL). These results suggest that hypoxia is not a direct dyspnogenic factor in healthy individuals capable of breathing without restriction at rest.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dyspnea; High altitude; Hypoxemia; Hypoxia; Hypoxic ventilatory response

Mesh:

Year:  2015        PMID: 26219585     DOI: 10.1016/j.resp.2015.07.009

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  3 in total

Review 1.  Silent hypoxaemia in COVID-19 patients.

Authors:  Tatum S Simonson; Tracy L Baker; Robert B Banzett; Tammie Bishop; Jerome A Dempsey; Jack L Feldman; Patrice G Guyenet; Emma J Hodson; Gordon S Mitchell; Esteban A Moya; Brandon T Nokes; Jeremy E Orr; Robert L Owens; Marc Poulin; Jean M Rawling; Christopher N Schmickl; Jyoti J Watters; Magdy Younes; Atul Malhotra
Journal:  J Physiol       Date:  2021-01-04       Impact factor: 6.228

2.  Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome.

Authors:  Michele Ferrari; Isha H Jain; Olga Goldberger; Emanuele Rezoagli; Robrecht Thoonen; Kai-Hung Cheng; David E Sosnovik; Marielle Scherrer-Crosbie; Vamsi K Mootha; Warren M Zapol
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-08       Impact factor: 11.205

3.  Syncope and silent hypoxemia in COVID-19: Implications for the autonomic field.

Authors:  Jacquie Baker; Anthony V Incognito; Richard J A Wilson; Satish R Raj
Journal:  Auton Neurosci       Date:  2021-07-06       Impact factor: 3.145

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.